Sylvin H, Kumlin M, Alving K
Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Inflamm Res. 2003 May;52(5):185-90. doi: 10.1007/s000110300070.
The role of cysteinyl leukotrienes (cysLTs) in the acute allergic airway reaction in the pig was investigated, with focus on the effects on the bronchial circulation, and compared with histamine-induced effects.
31 barrier-bred pigs were used, of which 24 pigs were actively-sensitised to Ascaris suum.
Leukotriene D(4) (LTD(4)) and histamine were injected intravenously (i.v.) and given as an aerosol to non-sensitised pigs. Seventeen animals, sensitised to Ascaris suum, were challenged with Ascaris antigen aerosol. The effect of MK-571, a CysLT(1)-receptor antagonist, on LTD(4)- and allergen-induced responses were investigated.
LTD(4) (2 nmol/kg) i.v. injection increased the airways resistance (R(aw)) by 46 +/- 20% and reduced bronchial vascular conductance (BVC) by 38 +/- 2%. Both these effects were blocked by MK-571 (0.1 mg/kg i.v.). Histamine injections (i.v.) in equimolar doses caused similar dose-dependent increases in R(aw), (22 +/- 7%) but induced vasodilatation and an increase in BVC (22 +/- 8%). Aerosolised LTD(4) (4 nmol/kg) caused a decrease in BVC but did not affect R(aw). In sensitised pigs, challenge with Ascaris aerosol led to an acute increase in Raw (198 +/- 57%) and increase in BVC (62 +/- 35%). MK-571 (0.5 mg/kg i.v.) pre-treatment did not significantly affect these responses (n = 9).
LTD(4) causes constriction of the pig bronchi and of the bronchial circulation via activation of the CysLT(1) receptor and may counteract histamine-induced vasodilatory effects. However, in the allergen-induced acute airway response in the pig, cysLTs do not seem to be important bronchoconstrictive mediators.